Manuel Bardiès sur LinkedIn
Manuel Bardiès - Chercheur - INSERM - LinkedIn
Directeur de Recherches INSERM · Dr. Manuel Bardiès (Web Of Science Research ID: L-3136-2014) is working in Montpellier Institute for Cancer Research (IRCM) ...
Manuel Bardiès on LinkedIn: Welcome
EFOMP Policy Statement 19 on Dosimetry in Nuclear Medicine Therapy – Molecular Radiotherapy was approved by EFOMP 36 National Member ...
Manuel Bardiès on LinkedIn: Radiopharmaceuticals as ...
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors.
Manuel Bardiès' Post - European Cancer Organisation - LinkedIn
EFOMP Policy Statement n°19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy is mentioned in https://lnkd.in/ej7kpxpB A big ...
Manuel Bardiès on LinkedIn: Basic dosimetry and radiobiology for ...
Since 2001, he has been fully engaged at the Department of Molecular Biology and Genetics, serving as the head of the DNA Repair group at the ...
Manuel Bardiès on LinkedIn: It's worth learning French just to attend ...
Manuel Bardiès' Post. View profile for Manuel ... de très belles conférences, de discussions riches et de ... Ensemble, nous avons pu former une ...
Manuel Bardiès on LinkedIn: Webinar Series 2024
Topic: Radiobiology for radionuclide therapy & dosimetry During this Scientific Meeting, we will look into radiobiological effects of ...
Manuel Bardiès on LinkedIn: Webinar Series 2024
We are happy to announce the next online European Federation Of Organizations For Medical Physics - EFOMP SIGFRID Dosimetry Case Report ...
Manuel Bardiès on LinkedIn: Nuclear Medicine dosimetry at ECMP ...
Nuclear Medicine dosimetry at ECMP chaired by Lidia Strigari. Excellent talk by Marta Cremonesi. #ECMP #EFOMP Marta Cremonesi Lidia ...
Manuel Bardiès' Post - ecmp #efomp - LinkedIn
Dr. Naureen Nizar from SIUT's Nuclear Medicine Department highlights the rigorous safety protocols in place to protect patients during ...
Manuel Bardiès on LinkedIn: Dosimetry for Radiopharmaceutical ...
Medical Strategist focusing on Radiopharmaceuticals in Prostate & Rare Cancers. Forever an Educator & Advocate. 5mo.
Manuel Bardiès on LinkedIn: Very proud to have been part of the ...
Very proud to have been part of the "COST Action RATIONALE - an overview of challenges in radionuclide theranostics" session, during the ...
Manuel Bardiès' Post - efomp #aapm #iomp #iaea - LinkedIn
Last day, last session, last speaker… Thanks to all attendees, and thank you to the organisers. I'm very lucky to have attended that ...
Manuel Bardiès on LinkedIn: #sig_frid #nuclearmedicnedosimetry
So glad to have met again John Humm at the AAPM meeting in LA! I've been a fan for ... a long time! #SIG_FRID #NuclearMedicneDosimetry.
Manuel Bardiès on LinkedIn: #sasnm
Thanks to Stuart M. and the South African colleague for their kind invitation to #SASNM Masterclass in Cape Town.
Manuel Bardiès posted on LinkedIn
Really enjoyed the #EANM22 conference in Barcelona! Proud to have presented on the necessity of dosimetry in molecular radiotherapy during ...
Manuel Bardiès on LinkedIn: Another SIG_FRID initiative Don't miss ...
The EFOMP Special Interest Group for Radionuclide Internal Dosimetry will host the next online Dosimetry Case Report meeting: Tuesday, ...
Manuel Bardiès on LinkedIn: Accuracy and uncertainty analysis of ...
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and ...
Manuel Bardiès on LinkedIn: #dosimetry #medicalphysics
Manuel Bardiès' Post · Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose · More Relevant Posts.
What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice
... Manuel Bardiès. 1Department of Nuclear Medicine, Institut du Cancer de Montpellier, Université de Montpellier, Montpellier, France;. 2Institut ...